To Evaluate the Efficacy and Safety of Multifocal Soft Contact Lens in Myopia Control

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

59 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-05-02

Study Completion Date

2020-03-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this study is to investigate the efficacy and safety of soft lens in myopia control.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

To Evaluate the Efficacy and Safety of Aspherical Soft Contact Lens in Myopia Control

NCT04238897

Myopia

COMPLETED NA

Soft Peripheral Contact Lens for Eye Elongation Control (SPACE):1-year Results of a Double-blinded Randomized Con-trolled Trial

NCT05733884

Soft Contact Lens

COMPLETED NA

A Clinical Comparison of Two Daily Disposable Soft Contact Lenses

NCT04005885

Myopia

COMPLETED NA

Short-term Clinical Performance of Multifocal Soft Contact Lens

NCT05273606

Myopia

UNKNOWN NA

Novel Multifocal Soft Contact Lens Study

NCT06172881

Myopia

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a prospective, randomized, paired eye comparison, double-blind study aims to evaluate the efficacy and safety of "Soft Lens" in myopia control among schoolchildren. A total of 118 eyes are planned to be enrolled and the expect duration of subject participation will be 48 weeks not including two weeks of screening period. Data such as refractive error, axial length, visual acuity, average wearing hours, self-assessment, adverse events etc. will be collected during the study. A total of 10 visits, i.e. a screening visit, a randomization visit, and 8 treatment visits are planned. Subjects will be encouraged to complete all planned visits.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Myopia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Paired-eye comparison

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group A

Intervention name: multifocal soft contact lens/single vision soft contact lens

Left eye: multifocal soft contact lens Right eye: single vision soft contact lens

Group Type OTHER

soft contact lens

Intervention Type DEVICE

Group A

Group B

Group B

Intervention name: multifocal soft contact lens/single vision soft contact lens

Left eye: single vision soft contact lens Right eye: multifocal soft contact lens

Group Type OTHER

soft contact lens

Intervention Type DEVICE

Group A

Group B

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

soft contact lens

Group A

Group B

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Both genders aged between 6 and 15 years
2. Spherical equivalent refractive error between -1.00D and -10.00D
3. Visual acuity with contact lens of 20/25 or better in each eye
4. Astigmatism less than or equal to 1.50D
5. Anisometropia less than or equal to 1.00D
6. Agree to wear assigned contact lens and able to comply with the study protocol
7. Subjects and/or their legal representatives agree to sign informed consent form

Exclusion Criteria

1. Eye disease or vision problem that may contraindicate/interfere with contact lens wearing, for example:

1. Amblyopia
2. Severe strabismus at investigator's discretion
3. Pathologically dry eye
4. Aphakia
5. Slit lamp findings including but not limited to corneal edema, corneal ulcer, bulbar redness that are more serious than grade 1
6. Currently ocular infection of any type or inflammation in either eye
7. Oculomotor nerve palsies
8. Pupil or lid abnormality in either eye
9. Severe ocular allergy
10. Anterior segment infection, inflammation or abnormality
11. Corneal vascularization greater than 1 mm of penetration
12. History of herpetic keratitis
2. Use of bifocals, progressive addition lenses, rigid gas permeable contact lenses, orthokeratology lenses, atropine, pirenzepine or any other myopia control treatment within 1 month prior to screening visit
3. Systemic disease that may affect vision or contact lens wearing (e.g. diabetes, Down syndrome), autoimmune disease, infectious disease, or immunosuppressive diseases recorded in medical charts or informed by caregiver
4. Surgically altered eyes (e.g. corneal or refractive surgery, not including stye removal surgery)
5. Receiving any medication for long-term use which may interfere with contact lens wearing, tear film production, pupil size, accommodation or refractive state, such as nasal decongestants (e.g. pseudoephedrine, phenylephrine), antihistamines (e.g. chlorpheniramine, diphenhydramine), Prednisolone or Ritalin (methyphenidate)

Minimum Eligible Age

6 Years

Maximum Eligible Age

15 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes